Previous close | 2.7400 |
Open | 2.7400 |
Bid | 2.7500 x 800 |
Ask | 2.8100 x 800 |
Day's range | 2.6700 - 2.8100 |
52-week range | 0.5000 - 3.2200 |
Volume | |
Avg. volume | 3,076,078 |
Market cap | 416.411M |
Beta (5Y monthly) | 1.68 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Heron Therapeutics ( NASDAQ:HRTX ) Full Year 2023 Results Key Financial Results Revenue: US$127.0m (up 18% from FY...
Heron Therapeutics, Inc. (NASDAQ:HRTX) Q4 2023 Earnings Call Transcript March 12, 2024 Heron Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you for standing by, and welcome to the Heron Therapeutics Fourth Quarter 2023 Conference Call. I […]
Q4 2023 Heron Therapeutics Inc Earnings Call